Literature DB >> 27162838

Prognostic Factors for Fournier's Gangrene; A 10-year Experience in Southeastern Iran.

Amene Sabzi Sarvestani1, Mehdi Zamiri1, Mehdi Sabouri1.   

Abstract

OBJECTIVES: To describe the characteristics and prognostic factors of 28 patients with Fournier's Gangrene (FG) referred to our medical center at Southeastern Iran.
METHODS: This was a cross-sectional study including 28 cases of FG that were operated in Surgery department of Zahedan University of Medical Sciences during a 10-year period from April 2002 to March 2012. The study analyzed 9 parameters including the body temperature, heart rate, respiratory rate, hematocrit, white blood count (WBC), and serum levels of sodium, potassium, creatininee (twice for 2 for acute renal failure), and bicarbonate for Fournier Gangrene Severity Index (FGSI) score. The aspects taken into account were age, gender, predisposing factors, duration of symptoms, hospitalization period, and number of debridements, disease outcome and the FGSI.
RESULTS: All patients were males, aged from 26 to 68 years, with mean age 44.6 ±8.49 years. Statistically significant differences in age (p<0.001), duration of symptoms (p=0.001), number of debridements (p=0.006), hospitalization duration (p<0.001) and FGSI (p<0.001) were found between surviving and dead patients. The mortality rate was 35.7%, and the most common presentation was perianal/scrotal pain (78.6%). Perianal and primary scrotal abscesses were most common causes of FG and were found in 57.14% and 21.42% of patients respectively. The most prevalent predisposing factor was diabetes mellitus in 12 (42.85%) patients. With respect to laboratory findings, statistically significant differences in WBC (p=0.002), creatinine (p<0.001), albumin (p<0.001), calcium (p<0.001) and serum sodium (p=0.035) were found between the surviving and dead patients.
CONCLUSION: Serious outcome of FG was associated with old age, delayed diagnosis and treatment, inadequate surgical debridement, shorter hospitalization and higher FGSI scores. In addition higher WBC, higher creatininee and serum sodium and lower albumin and calcium levels implicated worse prognosis.

Entities:  

Keywords:  Fournier’s gangrene; Iran; Prognosis; Prognostic factors

Year:  2013        PMID: 27162838      PMCID: PMC4779172     

Source DB:  PubMed          Journal:  Bull Emerg Trauma        ISSN: 2322-2522


  36 in total

1.  Hyperbaric oxygen therapy in the treatment of Fournier's disease in 11 male patients.

Authors:  R Pizzorno; F Bonini; A Donelli; R Stubinski; M Medica; G Carmignani
Journal:  J Urol       Date:  1997-09       Impact factor: 7.450

2.  Genital Fournier's gangrene: experience with 38 patients.

Authors:  M J Hejase; J E Simonin; R Bihrle; C L Coogan
Journal:  Urology       Date:  1996-05       Impact factor: 2.649

3.  Fournier's gangrene: an analysis of repeated surgical debridement.

Authors:  Sam N Chawla; Christina Gallop; Jack H Mydlo
Journal:  Eur Urol       Date:  2003-05       Impact factor: 20.096

4.  Fournier's gangrene: risk factors and strategies for management.

Authors:  Hakan Yanar; Korhan Taviloglu; Cemalettin Ertekin; Recep Guloglu; Unal Zorba; Neslihan Cabioglu; Irfan Baspinar
Journal:  World J Surg       Date:  2006-09       Impact factor: 3.352

Review 5.  Fournier's gangrene: a review of 1726 cases.

Authors:  N Eke
Journal:  Br J Surg       Date:  2000-06       Impact factor: 6.939

6.  Fournier's Gangrene: population based epidemiology and outcomes.

Authors:  Mathew D Sorensen; John N Krieger; Frederick P Rivara; Joshua A Broghammer; Matthew B Klein; Christopher D Mack; Hunter Wessells
Journal:  J Urol       Date:  2009-03-14       Impact factor: 7.450

7.  Fournier's gangrene: evaluation of 68 patients and analysis of prognostic variables.

Authors:  H R Unalp; E Kamer; H Derici; K Atahan; U Balci; C Demirdoven; O Nazli; M A Onal
Journal:  J Postgrad Med       Date:  2008 Apr-Jun       Impact factor: 1.476

8.  Fournier's gangrene: a monographic urology center experience with twenty patients.

Authors:  R Martínez-Rodríguez; J Ponce de León; J Caparrós; H Villavicencio
Journal:  Urol Int       Date:  2009-10-13       Impact factor: 2.089

Review 9.  [Fournier's gangrene: anatomo-clinical features in adults and children. Therapy update].

Authors:  A Rodríguez Alonso; M D Pérez García; A Núñez López; A Ojea Calvo; A Alonso Rodrigo; B Rodríguez Iglesias; J M Barros Rodríguez; J Benavente Delgado; J L Nogueira March
Journal:  Actas Urol Esp       Date:  2000-04       Impact factor: 0.994

10.  Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality.

Authors:  Chin-Ho Wong; Haw-Chong Chang; Shanker Pasupathy; Lay-Wai Khin; Jee-Lim Tan; Cheng-Ooi Low
Journal:  J Bone Joint Surg Am       Date:  2003-08       Impact factor: 5.284

View more
  5 in total

1.  Pattern and outcome of management of Fournier's gangrene in a resource-constraint setting.

Authors:  Ngwobia Peter Agwu; Abubakar Sadiq Muhammad; Abdulwahab-Ahmed Abdullahi; Bello Bashir; Jacob Ndas Legbo; Ismaila Arzika Mungadi
Journal:  Urol Ann       Date:  2020-07-17

2.  An Extremely Rare Complication of Widespread Retroperitoneal Abscess Originating from Anorectal Horseshoe Abscess.

Authors:  Faruk Pehlivanli; Oktay Aydin; Gökhan Karaca; Gülçin Aydin; Çağatay Erden Daphan
Journal:  Bull Emerg Trauma       Date:  2019-01

3.  Fournier's Gangrene: validation of the severity index.

Authors:  Ahmed Itaimi; Wissem Triki; Imed Abbassi; Karim Ayed; Oussama Baraket; Sami Bouchoucha
Journal:  Tunis Med       Date:  2022 fevrier

4.  Management of Fournier's gangrene during the Covid-19 pandemic era: make a virtue out of necessity.

Authors:  Alessio Paladini; Giovanni Cochetti; Angelica Tancredi; Matteo Mearini; Andrea Vitale; Francesca Pastore; Paolo Mangione; Ettore Mearini
Journal:  Basic Clin Androl       Date:  2022-07-19

5.  Fournier's Gangrene: Clinical Presentation of 13 Cases.

Authors:  Bolesław Kuzaka; Marta M Wróblewska; Tomasz Borkowski; Dariusz Kawecki; Piotr Kuzaka; Grażyna Młynarczyk; Piotr Radziszewski
Journal:  Med Sci Monit       Date:  2018-01-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.